Cyclo Therapeutics Reports Positive Data From Phase 1 Study On Trappsol Cyclo For NPC Treatment

Cyclo Therapeutics Inc. (CYTH) announced new positive safety and efficacy data from ongoing phase 1 open-label extension study of trappsol cyclo for the treatment of niemann-pick disease type C1 or NPC. NPC is a rare, progressive and fatal genetic disorder characterized by abnormal accumulation of cholesterol in cells.

The data provide additional support for the capacity of Trappsol Cyclo to stabilize disease progression with home-based intravenous infusions in Niemann-Pick Disease Type C1, the company said in a statement.

Trappsol Cyclo is currently being evaluated in the pivotal Phase 3 study, TransportNPC, for the treatment of NPC1. Cyclo Therapeutics received Orphan Drug Designation for Trappsol Cyclo to treat NPC1 in both the US and EU and Fast Track and Rare Pediatric Disease Designations in the US.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has rolled out the tipping feature called "Tips" for everyone around the globe using the microblogging site with more payment options to choose from, including cryptocurrencies such as Bitcoin. This is a new way for people to receive and show support on Twitter with money. The feature is currently available on iOS and will be available on Android over the coming weeks. Amazon.com has launched weekly Max-Your-Vax Sweepstakes to encourage their employees to get vaccinated against COVID-19. The sweepstakes began on August 6, 2021 and ends on October 21, 2021, with six draws during the sweepstakes period for 18 prizes worth nearly $2 million, including cash prizes, new vehicle or cash and vacation plus 40 hours of Paid Time Off. Target Corp. announced its plans to hire 100,000 seasonal team members at its stores across the country for this holiday shopping season, though fewer than previous years. With this, the company aims to invest in more flexible scheduling, training, pay and benefits for its existing team members. In a statement, the company said it is also offering around 5 million more hours to its existing staff.
Follow RTT